Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNA-seq data of LP1 multiple myeloma cell line treated for 6h or 24h with Tasquinimod


ABSTRACT: Tasquinimod is a new immunomodulatory treatment for MM that is in phase I/II clinical evaluation in patients with relapsed/refractory MM. In the present study, we evaluated the effect of tasquinimod on MM cells using RNA sequencing to provide more mechanistic insights into the observed tasquinimod-mediated anti-tumor effects.

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo sapiens

SUBMITTER:  

PROVIDER: E-MTAB-11787 | biostudies-arrayexpress |

SECONDARY ACCESSION(S): ERP138156

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2023-12-01 | E-MTAB-13095 | biostudies-arrayexpress
2023-08-31 | E-MTAB-13121 | biostudies-arrayexpress
2016-08-11 | E-GEOD-85422 | biostudies-arrayexpress
2021-07-26 | E-MTAB-9939 | biostudies-arrayexpress
2019-11-12 | PXD010845 | Pride
2020-11-09 | LDS-1592 | LINCS
2020-11-09 | LDS-1587 | LINCS
2022-02-16 | PXD024046 | Pride
2023-08-11 | PXD040948 | Pride
2021-04-30 | E-MTAB-9941 | biostudies-arrayexpress